Atrys to list on Mab tomorrow (Friday) after capital increase

Integral service around a transaction
BY : Diego GutiérrezJuly Thu, 2016
Atrys will make its debut tomorrow on the MAB, after receiving the approval of the MAB incorporations committee. The company, which is the 35th company to be listed in the growth company category, is engaged in the provision of diagnostic services and medical treatments and the development of new therapeutic modalities and diagnostic tools.


 About Atrys

Atrys was founded in 2007 by a group of physicians and cancer experts led by Dr. Carlos Cordón-Cardó, director of the Department of Pathology at Mount Sinai Hospital (New York, USA). Its aim was to provide a new model in the clinical management of cancer by combining innovative precision diagnostic techniques in pathology and molecular anatomy with new radiotherapy treatments. 

It currently operates in Opera in America and Europe, with clients in 7 countries, the United States, Switzerland, the United Kingdom, Germany, Denmark, Portugal and Spain. It closed 2015 with a turnover of €2.8m and 50 employees.

In 2015 it acquired eDiagnostic, a telemedicine company offering services in the specialties of Radiology, Cardiology, Ophthalmology and Dermatology.

Preparing to go out to the Mab: Capital increase

In preparation for its Mab listing, Atrys has carried out a €4.5m capital increase to raise equity to finance the opening of new radiotherapy centres and new diagnostic services, as well as the company's international expansion.

The shareholders of Atrys are InvereadyThe venture capital investment group (37.6 %); the scientific and management team (37 %) and the rest of the shareholding Family Offices.

The shareholders of Atrys are willing to remain in the capital and have made a 12-month commitment to stay in the company.

Details of your exit to the Mab

Tomorrow this company will debut on the Mab, initial capitalisation at €16.5M. According to a statement from BME, the reference price will be €1.48 per share.

The company will be listed on the MAB through the price fixing system by means of the confluence of supply and demand in two daily auction periods or "fixings" (12.00 p.m. and 4.00 p.m.).

Norgestión is the company's registered advisor and Banco Sabadell acts as liquidity provider.

Other posts that may interest you

Agile buys OTTN

Clerhp structures exits the mab up 10.24%

TECNOQUARK goes public on the MAB to finance growth

If you are thinking of going public on the MAB, contact us. Abra-Invest has an expert team that will advise you to make the process a success. Call us at + 34 946424142 or fill in the contact form.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?